A group of researchers at the University of Texas at El Paso is working on making it cheaper, faster and easier to test for meningitis and pertussis. Dr. XiuJun “James” Li, assistant professor of chemistry, and Dr. Delfina C. Domínguez, professor of clinical laboratory sciences, have joined efforts to produce a paper-based biochip that can be used in schools, clinics and developing nations.
Dr. XiuJun “James” Li
A group of researchers at the University of Texas at El Paso is working on making it cheaper, faster and easier to test for meningitis and pertussis. Dr. XiuJun “James” Li, assistant professor of chemistry, and Dr. Delfina C. Domínguez, professor of clinical laboratory sciences, have joined efforts to produce a paper-based biochip that can be used in schools, clinics and developing nations.
Using chromatography paper, Li has developed a three-dimensional, paper-based microfluidic device that uses DNA amplification to provide a rapid, low-cost and highly sensitive method to diagnose whooping cough. The procedure involves placing a sample from a nasal swab in a device similar to a pregnancy test strip that will change color to indicate the presence of the bacteria. Results are available in 40 minutes.
It is similar to a device Li developed with a grant from the National Institute of General Medical Sciences to detect meningitis.
Clinical trials are being conducted now for whooping cough in collaboration with a California children’s hospital. Clinical trials for meningitis are pending.
So far, they have completed 50 percent of clinical samples obtained from the hospital, and achieved consistent results from the hospital. Testing is expected to be complete this summer.
The device does not require any specialized equipment; it offers super high-sensitivity. The detection limit is down to a few bacteria each assay, which is fully comparable with real-time PCR (~$60,000).
Source: University of Texas at El Paso
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.